PTPN22 Is Genetically Associated with Risk of Generalized Vitiligo, but CTLA4 Is Not
- 1 July 2008
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 128 (7), 1757-1762
- https://doi.org/10.1038/sj.jid.5701233
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity?Expert Reviews in Molecular Medicine, 2005
- CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseasesPigment Cell Research, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetesNature Genetics, 2004
- Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their FamiliesPigment Cell Research, 2003
- Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLAHuman Genetics, 2002
- Merlin—rapid analysis of dense genetic maps using sparse gene flow treesNature Genetics, 2001
- STUDY OF HLA CLASS I/II AND T LYMPHOCYTE SUBSETS IN KUWAITI VITILIGO PATIENTSInternational Journal of Immunogenetics, 1995
- Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental typeBritish Journal of Dermatology, 1993
- Genetic nature of vitiligoJournal of Dermatological Science, 1992